$199.00 – $449.00Price range: $199.00 through $449.00
Initial charge of $39 for consultation. Medication is charged only after provider approval.
A personalized, once-weekly prescription treatment combining Tirzepatide with vitamin B6. Tirzepatide activates both GIP and GLP-1 receptors involved in appetite regulation and metabolic function. Vitamin B6 supports several normal metabolic processes, including protein metabolism, neurotransmitter production, immune function, and hemoglobin formation.
Tirzepatide + B6 is a prescription-only compounded medication intended for eligible patients participating in a clinician-guided weight-management program. Tirzepatide is a dual GIP and GLP-1 receptor agonist. It affects biological pathways involved in appetite, caloric intake, insulin response, and gastric emptying. Vitamin B6 is an essential nutrient involved in more than 100 enzyme reactions. It contributes to normal protein, carbohydrate, and lipid metabolism and supports neurotransmitter production, immune function, and hemoglobin formation. The inclusion of B6 should not be interpreted as evidence that this formulation produces greater weight loss or fewer side effects than Tirzepatide alone. Your provider will determine whether this formulation is clinically appropriate based on your health history, medications, nutritional considerations, and treatment goals. Important note: Compounded medications are not reviewed or approved by the FDA. This medication is prepared for an individual patient by a licensed compounding pharmacy following a provider’s prescription.
This formulation combines Tirzepatide’s dual-pathway activity with the established nutritional functions of vitamin B6. Tirzepatide
Tirzepatide + B6 may be considered when a licensed provider determines that a patient-specific compounded formulation is clinically appropriate. Potential treatment features include:
Eligibility is determined by a licensed provider after reviewing your health history, current medications, BMI, weight-related health conditions, and treatment goals. The general populations studied for FDA-approved Tirzepatide weight-management treatment include: BMI General guidance Below 27 Generally outside standard weight-management criteria 27–29.9 May qualify with at least one weight-related health condition 30 or higher May qualify, subject to clinical review Weight-related conditions may include high blood pressure, abnormal cholesterol levels, obstructive sleep apnea, cardiovascular disease, or type 2 diabetes. This chart is provided only as general guidance. It does not guarantee eligibility, a prescription, or access to a compounded formulation.
Use Tirzepatide + B6 exactly as directed by your prescribing provider and dispensing pharmacy. General administration may include:
Your treatment package may include:
How is Tirzepatide + B6 different from Tirzepatide + B12? Both formulations use Tirzepatide as the primary treatment ingredient. The difference is the accompanying vitamin. The B12 formulation contains vitamin B12, while the B6 formulation contains vitamin B6. These vitamins perform different nutritional functions in the body. There is currently no established evidence that adding B6 makes Tirzepatide more effective for weight loss or more tolerable than Tirzepatide alone or Tirzepatide + B12. Your provider will determine which available formulation is appropriate for you. Is compounded Tirzepatide + B6 FDA-approved? No. Compounded Tirzepatide + B6 is not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, manufacturing quality, or equivalence to an FDA-approved medication before they are dispensed. FDA-approved medications containing Tirzepatide are separate products and should not be presented as interchangeable with a compounded formulation. Is Tirzepatide + B6 safe for long-term use? Long-term treatment decisions must be made by a licensed provider. FDA-approved Tirzepatide has been evaluated in clinical studies, but a specific compounded Tirzepatide + B6 formulation has not undergone FDA review. Safety also depends on the exact concentration, ingredients, pharmacy preparation, patient history, other medications, and ongoing monitoring. Your provider should periodically evaluate treatment response, side effects, hydration, nutritional intake, blood-glucose medications, and whether continued treatment remains appropriate. When might I notice changes? Individual experiences vary. Some patients may notice changes in appetite or fullness before observing meaningful changes in weight or metabolic measurements. Your provider will monitor your response and may gradually adjust your dose based on tolerability and clinical progress. No specific result or timeline can be guaranteed. Can I transition to an FDA-approved Tirzepatide product later? Potentially. Your provider can discuss FDA-approved treatment options and determine whether transitioning is clinically appropriate. Do not switch products, concentrations, or doses without provider instructions. A compounded vial and an FDA-approved Tirzepatide product may have different concentrations, delivery systems, and dosing instructions.
Do Not Use This Medication If You:
Compounded drugs are not reviewed or approved by the FDA. The FDA does not verify their safety, effectiveness, manufacturing quality, or equivalence to an FDA-approved medication before they are marketed. Tirzepatide + B6 should only be offered when legally available and when a licensed provider determines that a patient-specific compounded formulation is clinically appropriate. Pentavia does not practice medicine or make prescribing decisions. All prescriptions and clinical decisions are made independently by licensed healthcare providers. Product concentration, ingredients, dosing, pricing, pharmacy partner, state availability, storage requirements, beyond-use date, and packaging may vary and must be confirmed before this page is published. Images are for illustrative purposes. Actual product packaging and appearance may vary by dispensing pharmacy. Individual experiences and results vary.
